Marshall Wace North America’s Health Catalyst HCAT Stock Holding History

Marshall Wace North America’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,082	Closed	-$396K	–	1605
2020 Q4	$396K	Buy	+9,082	New	+$335K	﹤0.01%	1127
2020 Q3	–	Sell	-22,677	Closed	-$661K	–	1315
2020 Q2	$661K	Buy	22,677 +12,105	+115%	+$335K	﹤0.01%	864
2020 Q1	$277K	Buy	10,572 +6,863	+185%	+$210K	﹤0.01%	860
2019 Q4	$129K	Sell	3,709 -8,559	-70%	-$283K	﹤0.01%	1033
2019 Q3	$388K	Buy	+12,268	New	+$483K	﹤0.01%	848

Other funds holding HCAT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Marshall Wace North America's HCAT Position: Q1 2021 in Review

Marshall Wace North America sold out of Health Catalyst (HCAT) in Q1 2021, closing a stake of 9,082 shares — an estimated $396K sold.

Marshall Wace North America first reported a position in HCAT in Q3 2019 and held it in 5 quarters. The position peaked at $661K in Q2 2020. 190 funds tracked by Wall St. Rank hold HCAT as of Q1 2021.

Marshall Wace North America reported no remaining Health Catalyst position as of Q1 2021 after selling out during the quarter.
Marshall Wace North America sold 9,082 Health Catalyst shares in Q1 2021, an estimated $396K.
Marshall Wace North America first reported a position in Health Catalyst in Q3 2019 and held it in 5 quarters.
Marshall Wace North America's Health Catalyst position peaked at $661K in Q2 2020.
190 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.